Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and assess the safety of CD07805/47 gel
0.5% applied topically once daily versus azelaic acid gel 15% applied topically twice daily
in subjects with moderate to severe facial erythema of rosacea.